Page last updated: 2024-08-21

cyclopentane and Leukemia, Prolymphocytic, T-Cell

cyclopentane has been researched along with Leukemia, Prolymphocytic, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Berger, A; Best, S; Bruss, N; Danilov, AV; Danilova, OV; Kittai, A; Lam, V; Lind, EF; Liu, T; Murray, S; Pennock, ND	1

Other Studies

1 other study(ies) available for cyclopentane and Leukemia, Prolymphocytic, T-Cell

Article	Year
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells. Leukemia, 2021, Volume: 35, Issue:1 Topics: Antineoplastic Agents; Cell Line, Tumor; Cyclopentanes; Enzyme Inhibitors; Humans; Immunomodulation; Leukemia, Prolymphocytic, T-Cell; Lymphocyte Activation; Models, Biological; NEDD8 Protein; Pyrimidines; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes; T-Lymphocytes, Helper-Inducer	2021

Article

Year

Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells.

Leukemia, 2021, Volume: 35, Issue:1

Topics: Antineoplastic Agents; Cell Line, Tumor; Cyclopentanes; Enzyme Inhibitors; Humans; Immunomodulation; Leukemia, Prolymphocytic, T-Cell; Lymphocyte Activation; Models, Biological; NEDD8 Protein; Pyrimidines; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes; T-Lymphocytes, Helper-Inducer

2021